In this study, we will test a new influenza (flu) vaccine called the “Flu seasonal mRNA vaccine”. The investigational vaccine is designed to work against the influenza virus. This study is being done to test whether the new study vaccine is safe and how the human body reacts to it.
The purpose of this study is to assess the safety of different doses of CRV-101 and its effect on the immune system in comparison to SHINGRIX®, an FDA approved Shingles vaccine, in adults aged 50 years and older.
The purpose of this research study is to test an experimental drug called ORMD-0801, an orally administered formulation of insulin.
The purpose of this research is to test the safety of an investigational vaccine to prevent urinary tract infections.
The purpose of this study is to compare 2 different study vaccine doses by evaluating immune system responses (the body’s defense system) and reactions after the study vaccinations. In addition, this study will compare the reactions following the vaccination with the MVA‑BN‑WEV study vaccine or placebo.
The purpose of this research is to assess the safety and efficacy of IMM01-STEM in senior participants with muscle weakness and obesity (Sarcopenic Obesity).
Researchers are testing an oral SARS-COV-2 vaccine tablet to see if this experimental vaccine will help in the prevention of COVID-19 infection or symptoms due to COVID-19 infection. This study will also evaluate how well people tolerate taking the study vaccine.
You are invited to take part in this clinical trial because currently, there is no approved vaccine for the prevention of acute gastroenteritis (AGE) caused by norovirus. Acute gastroenteritis, commonly known as the stomach flu or stomach bug, is characterized by symptoms such as nausea, vomiting, diarrhea, abdominal cramps, and sometimes fever. The purpose of this clinical trial is to evaluate an investigational vaccine to prevent AGE caused by a norovirus infection.
In this study, we will test a new influenza vaccine called the “Flu pandemic mRNA (H5) vaccine”. This study will look into whether the new study vaccine is safe and how the human body reacts to it.
The purpose of this clinical trial is to help develop a vaccine for prevention of acute gastroenteritis (AGE), also known as the stomach flu, caused by infection with norovirus. Currently, no vaccine is available for prevention of infection with norovirus.
The Phase 2 part of the clinical trial will consist of 2 periods: the base period and the booster extension period. You may have the option to continue in the booster extension period, depending on your eligibility as determined by your trial doctor.
